AFT Pharmaceuticals expands operations to South East Asia

The AFT Pharma group is delighted to expand its operations to South East Asia with the establishment of a regional office in Kuala Lumpur.

Mr Giles Moss has assumed leadership for this enterprise. Giles, originally a Pharmacist has held a number of senior Pharma positions in mid sized Pharma including in Asia.

“AFT is delighted to have someone with Giles experience and in depth knowledge of business in Asia involved. For AFT, it is a logical extension to expand close to home and this will build on earlier licensing deals in Asia dating back to 2008” said Dr Atkinson, AFT Pharma CEO.

November 20, 2025

AFT delivers 10th consecutive first half revenue increase

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…

Read More

November 12, 2025

AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market 

AFT Pharmaceuticals has launched its full Lipo-Sachets® range in the U.S., featuring advanced collagen and vitamin supplements powered by patented LI…

Read More

September 25, 2025

On track for $300m FY27 revenue; positive iron IV study result

– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …

Read More